ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,781, issued on June 2.

"Adenomyosis associated infertility and hdac inhibitors" was invented by Gueorgui Stamenov (Sofia, Bulgaria) and Mariyana Eneva (Sofia, Bulgaria).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new uses and methods of treatment. More specifically, the invention relates to new uses of histone deacetylase inhibitors (HDACI) such as valproic acid (VPA), for enhancing in vitro fertilization (IVF) in patients suffering with adenomyosis associated infertility."

The patent was filed on April 13, 2021, under Application No. 17/998,076.

*For further information, including images, charts and tables, pleas...